Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 5—May 2012
Research

Epidemic of Invasive Pneumococcal Disease, Western Canada, 2005–2009

Gregory J. TyrrellComments to Author , Marguerite Lovgren, Quazi Ibrahim, Sipi Garg, Linda Chui, Tyler J. Boone, Carol Mangan, David M. Patrick1, Linda Hoang, Greg B. Horsman, Paul Van Caeseele, and Thomas J. Marrie2
Author affiliations: Provincial Laboratory for Public Health (Microbiology) Edmonton, Alberta, Canada (G.J. Tyrrell, M. Lovgren, Q. Ibrahim, S. Garg, L Chui, T.J. Boone, C. Mangan, T.J. Marrie); University of Alberta, Edmonton (G.J. Tyrrell, M. Lovgren, Q. Ibrahim, S. Garg, L Chui, T.J. Boone, C. Mangan, T.J. Marrie); British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada (D.M. Patrick, L. Hoang); Saskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada (G.B. Horsman); Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada (P. Van Caeseele)

Main Article

Figure 4

Restriction fragment-length polymorphism pattern of Streptococcus pneumoniae serotype 5 from epidemic in western Canada, 2000–2009 (epidemic clone), determined by pulsed-field gel electrophoresis. The Colombia5-19 strain is from the Pneumococcal Molecular Epidemiology Network (www.sph.emory.edu/PMEN) (17).

Figure 4. . . Restriction fragment length polymorphism pattern of Streptococcus pneumoniae serotype 5 from epidemic in western Canada, 2000–2009 (epidemic clone), determined by pulsed-field gel electrophoresis. The Colombia5-19 strain is from the Pneumococcal Molecular Epidemiology Network (www.sph.emory.edu/PMEN) (17).

Main Article

References
  1. Ihekweazu  C, Basarab  M, Wilson  D, Oliver  I, Dance  D, George  R, Outbreaks of serious pneumococcal disease in closed settings in the post-antibiotic era: a systematic review. J Infect. 2010;61:21–7. DOIPubMed
  2. Hausdorff  WP, Feikin  DR, Klugman  KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis. 2005;5:83–93.PubMed
  3. Hodges  RG, MacLeod  CM. Epidemic pneumococcal pneumonia: V. Final consideration of the factors underlying the epidemic. Am J Hyg. 1946;44:237–43.PubMed
  4. Schroder  MC, Cooper  G. An epidemic of colds, bronchitis and pneumonia due to type V pneumococci. J Infect Dis. 1930;46:384–92.
  5. Henrichsen  J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol. 1995;33:2759–62.PubMed
  6. Park  IH, Pritchard  DG, Cartee  R, Brandao  A, Brandileone  MC, Nahm  M. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol. 2007;45:1225–33. DOIPubMed
  7. Proulx  JF, Dery  S, Jette  LP, Ismael  J, Libman  M, De Wals  P. Pneumonia epidemic caused by a virulent strain of Streptococcus pneumoniae serotype 1 in Nunavik, Quebec. Can Commun Dis Rep. 2002;28–16 [cited 2010 Aug 20]. http://www.collectionscanada.gc.ca/webarchives/20071220082953/http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/02vol28/dr2816ea.html
  8. Case definitions for diseases under national surveillance. Can Commun Dis Rep. 2000;26S3 [cited 2010 Aug 20]. http://www.collectionscanada.gc.ca/webarchives/20071121073753/http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/00vol26/26s3/index.html
  9. Facklam  RR, Washington  JA. Streptococcus and related catalase-negative gram-positive cocci. In: Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ, editors. Manual of clinical microbiology, 5th ed. Washington (DC): American Society for Microbiology; 1991. p. 238–57.
  10. Lund  R, Henrichsen  J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumonia. In: Bergan T, Norris JR, editors. Methods in microbiology, vol.12. New York: Academic Press, Inc.; 1978. p. 241–62
  11. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically; approved standard, seventh ed. Document M7–A7. Wayne (PA): The Institute; 2006.
  12. National Committee for Clinical Laboratory Standards. Methods for dilution susceptibility testing for bacteria that grow aerobically; approved standard, sixth ed. Document M7–A6.Wayne (PA): The Committee; 2003.
  13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement. Document M100–S12. Wayne (PA): The Committee; 2003.
  14. Chang  N, Chui  L. A standardized protocol for the rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. Diagn Microbiol Infect Dis. 1998;31:275–9. DOIPubMed
  15. Enright  MC, Spratt  BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology. 1998;144:3049–60. DOIPubMed
  16. Statistics Canada. Quarterly population estimates, national perspective—population. Statistics Canada. 2009 March 26; Table 1-1 [cited 2010 Oct 31]. http://www.statcan.gc.ca/pub/91-002-x/2008004/t002-eng.htm
  17. Tamayo  M, Sa-Leao  R, Santos Sanches  I, Castaneda  E, de Lencastre  H. Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia. J Clin Microbiol. 1999;37:2337–42.PubMed
  18. Hausdorff  WP. The roles of pneumococcal serotypes 1 and 5 in pediatric invasive disease. Vaccine. 2007;25:2406–12. DOIPubMed
  19. Campbell  JD, Kotloff  KL, Sow  SO, Tapia  M, Keita  MM, Keita  T, Invasive pneumococcal infections among hospitalized children in Bamako, Mali. Pediatr Infect Dis J. 2004;23:642–9. DOIPubMed
  20. Sow  SO, Hormazabal  JC, Tapia  M, Diallo  S, Campbell  JD, Kotloff  K, Serotype distribution of Streptococcus pneumoniae among children in Bamako, Mali. In: Proceedings of the 5th International Symposium on Pneumococci and Pneumococcal Diseases; 2006 Apr 2–6; Alice Springs, Central Australia. Sydney (Australia): Tour Hosts Pty. Limited. Abstract PO3.57.
  21. Fraser  D, Givon-Lavi  N, Bilenko  N, Dagan  R. A decade (1989–1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice. Clin Infect Dis. 2001;33:421–7. DOIPubMed
  22. Lagos  R, Munoz  A, San Martin  O, Heitmann  I, Loyola  H, Levine  MM. Secular variations in age incidence (Inc) and serotypes (St) causing invasive pneumococcal disease (IPD) in children 0–59 months of age (MoA) in the Metropolitan Region (MR) of Chile. In: Proceedings of the 5th International Symposium on Pneumococci and Pneumococcal Diseases; 2006 Apr 2–6; Alice Springs, Central Australia. Sydney (Australia): Tour Hosts Pty. Limited. Abstract PO3.34.
  23. Porat  N, Trefler  R, Dagan  R. Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel. J Clin Microbiol. 2001;39:1827–32. DOIPubMed
  24. Greenberg  D, Dagan  R, Muallem  M, Porat  N. Antibiotic-resistant invasive pediatric Streptococcus pneumoniae clones in Israel. J Clin Microbiol. 2003;41:5541–5. DOIPubMed
  25. Harrington  SM, Stock  F, Kominski  AL, Campbell  JD, Hormazabal  JC, Livio  S, Genotypic analysis of invasive Streptococcus pneumoniae from Mali, Africa, by semiautomated repetitive-element PCR and pulsed-field gel electrophoresis. J Clin Microbiol. 2007;45:707–14. DOIPubMed
  26. Firacative  C, Moreno  J, Rosales  P, Maldonado  A, Sánchez  J, Pesantes  C, Circulation of Streptococcus pneumoniae clone Colombia5 ST289 in nine Latin America countries. Rev Panam Salud Publica. 2009;23:337–43.[REMOVED HYPERLINK FIELD]
  27. Gamboa  L, Camou  T, Hortal  M, Castañeda  E; Sireva-Vigia Working Group. Dissemination of Streptococcus pneumoniae clone Colombia(5)-19 in Latin America. J Clin Microbiol. 2002;40:3942–50. DOIPubMed
  28. DeMaria  A, Browne  K, Berk  SL, Sherwood  EJ, McCabe  WR. An outbreak of type 1 pneumococcal pneumonia in a men’s shelter. JAMA. 1980;244:1446–9. DOIPubMed
  29. Mercat  A, Nguyen  J, Dautzenberg  B. An outbreak of pneumococcal pneumonia in two men’s shelters. Chest. 1991;99:147–51. DOIPubMed
  30. Plevneshi  A, Svoboda  T, Armstrong  I, Tyrrell  G, Miranda  A, Green  K, Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PLoS ONE. 2009;4:e7255. DOIPubMed
  31. Streptococcus pneumoniae, serotype 5,8—Canada (Alberta). ProMED-mail. 2006 Dec 9 [cited 2010 Aug 13]. http://www.promedmail.org, archive no. 20061214.3520.
  32. Streptococcus pneumoniae, serotype 5—Canada (British Columbia). ProMED-mail. 2006 Dec 12 [cited 2010 Aug 13]. http://www.promedmail.org, archive no. 20061209.3477.
  33. Vanderkooi  OG, Church  DL, MacDonald  J, Zucol  F, Kellner  JD. Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada. PLoS ONE. 2011;6:e28547. Epub 2011 Dec 27. DOIPubMed
  34. Dawar  M, Russell  B, McClean  K, Levett  P, Tyrrell  GJ, Irvine  J. A case of necrotizing fasciitis due to Streptococcus pneumoniae serotype 5 in Saskatchewan. Can J Infect Dis Med Microbiol. 2008;19:69–71.PubMed
  35. Statement on the recommended use of pneumococcal 23-valent polysaccharide vaccine in homeless persons and injection drug users. Can Commun Dis Rep. 2008;34(ACS-5):1–12 [cited 2010 Aug 30]. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/08vol34/acs-5/index-eng.php
  36. Romney  MG, Hull  MW, Gustafson  R, Sandhu  J, Champagne  S, Wong  T, Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population. Clin Infect Dis. 2008;47:768–74. DOIPubMed
  37. Kozoriz  K, Fraser  J, McKay  D, Grunert  B, Ferris  D, Parker  R. Serotype 5 invasive pneumococcal disease outbreak—Kelowna, British Columbia, Canada. Can Commun Dis Rep. 2008 [cited 2010 Aug 30]. http://www.phac-aspc.gc.ca/ccdrw-rmtch/2008/r0108-eng.php

Main Article

1Current affiliation: University of British Columbia, Vancouver, British Columbia, Canada.

2Current affiliation: Dalhousie University, Halifax, Nova Scotia, Canada.

Page created: April 12, 2012
Page updated: April 12, 2012
Page reviewed: April 12, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external